Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Associations of adult-attained height and early life energy restriction with postmenopausal breast cancer risk according to estrogen and progesterone receptor status.

Elands RJJ, Offermans NSM, Simons CCJM, Schouten LJ, Verhage BA, van den Brandt PA, Weijenberg MP.

Int J Cancer. 2019 Apr 15;144(8):1844-1857. doi: 10.1002/ijc.31890. Epub 2018 Nov 9.

PMID:
30252931
2.

A Pooled Analysis of 15 Prospective Cohort Studies on the Association between Fruit, Vegetable, and Mature Bean Consumption and Risk of Prostate Cancer.

Petimar J, Wilson KM, Wu K, Wang M, Albanes D, van den Brandt PA, Cook MB, Giles GG, Giovannucci EL, Goodman GE, Goodman PJ, Håkansson N, Helzlsouer K, Key TJ, Kolonel LN, Liao LM, Männistö S, McCullough ML, Milne RL, Neuhouser ML, Park Y, Platz EA, Riboli E, Sawada N, Schenk JM, Tsugane S, Verhage B, Wang Y, Wilkens LR, Wolk A, Ziegler RG, Smith-Warner SA.

Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1276-1287. doi: 10.1158/1055-9965.EPI-16-1006. Epub 2017 Apr 26.

3.

A systematic SNP selection approach to identify mechanisms underlying disease aetiology: linking height to post-menopausal breast and colorectal cancer risk.

Elands RJ, Simons CC, Riemenschneider M, Isaacs A, Schouten LJ, Verhage BA, Van Steen K, Godschalk RW, van den Brandt PA, Stoll M, Weijenberg MP.

Sci Rep. 2017 Jan 24;7:41034. doi: 10.1038/srep41034.

4.

A Systematic Literature Review and Meta-Regression Analysis on Early-Life Energy Restriction and Cancer Risk in Humans.

Elands RJ, Simons CC, Dongen Mv, Schouten LJ, Verhage BA, van den Brandt PA, Weijenberg MP.

PLoS One. 2016 Sep 19;11(9):e0158003. doi: 10.1371/journal.pone.0158003. eCollection 2016. Review.

5.

DNA from nails for genetic analyses in large-scale epidemiologic studies.

Hogervorst JG, Godschalk RW, van den Brandt PA, Weijenberg MP, Verhage BA, Jonkers L, Goessens J, Simons CC, Vermeesch JR, van Schooten FJ, Schouten LJ.

Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2703-12. doi: 10.1158/1055-9965.EPI-14-0552.

6.

Oxidative stress-related genetic variants, pro- and antioxidant intake and status, and advanced prostate cancer risk.

Geybels MS, van den Brandt PA, van Schooten FJ, Verhage BA.

Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):178-86. doi: 10.1158/1055-9965.EPI-14-0968. Epub 2014 Oct 14.

7.

Dietary one-carbon nutrient intake and risk of lymphoid and myeloid neoplasms: results of the Netherlands cohort study.

Heinen MM, van den Brandt PA, Schouten LJ, Goldbohm RA, Schouten HC, Verhage BA.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2153-64. doi: 10.1158/1055-9965.EPI-14-0136. Epub 2014 Jul 21.

8.

Selenoprotein gene variants, toenail selenium levels, and risk for advanced prostate cancer.

Geybels MS, van den Brandt PA, Schouten LJ, van Schooten FJ, van Breda SG, Rayman MP, Green FR, Verhage BA.

J Natl Cancer Inst. 2014 Mar;106(3):dju003. doi: 10.1093/jnci/dju003. Epub 2014 Feb 22.

PMID:
24563517
9.

Diabetes type II, other medical conditions and pancreatic cancer risk: a prospective study in The Netherlands.

Eijgenraam P, Heinen MM, Verhage BA, Keulemans YC, Schouten LJ, van den Brandt PA.

Br J Cancer. 2013 Nov 26;109(11):2924-32. doi: 10.1038/bjc.2013.629. Epub 2013 Oct 22.

10.

Advanced prostate cancer risk in relation to toenail selenium levels.

Geybels MS, Verhage BA, van Schooten FJ, Goldbohm RA, van den Brandt PA.

J Natl Cancer Inst. 2013 Sep 18;105(18):1394-401. doi: 10.1093/jnci/djt186. Epub 2013 Jul 22.

PMID:
23878355
11.

Dietary flavonoid intake, black tea consumption, and risk of overall and advanced stage prostate cancer.

Geybels MS, Verhage BA, Arts IC, van Schooten FJ, Goldbohm RA, van den Brandt PA.

Am J Epidemiol. 2013 Jun 15;177(12):1388-98. doi: 10.1093/aje/kws419. Epub 2013 May 30.

PMID:
23722011
12.

Alcohol consumption and risk of lymphoid and myeloid neoplasms: results of the Netherlands cohort study.

Heinen MM, Verhage BA, Schouten LJ, Goldbohm RA, Schouten HC, van den Brandt PA.

Int J Cancer. 2013 Oct 1;133(7):1701-12. doi: 10.1002/ijc.28175. Epub 2013 Apr 24.

13.

Dietary folate and folate vitamers and the risk of prostate cancer in The Netherlands Cohort Study.

Verhage BA, Cremers P, Schouten LJ, Goldbohm RA, van den Brandt PA.

Cancer Causes Control. 2012 Dec;23(12):2003-11. doi: 10.1007/s10552-012-0079-7. Epub 2012 Oct 30.

PMID:
23109170
14.

Measures of combined antioxidant and pro-oxidant exposures and risk of overall and advanced stage prostate cancer.

Geybels MS, Verhage BA, van Schooten FJ, van den Brandt PA.

Ann Epidemiol. 2012 Nov;22(11):814-20. doi: 10.1016/j.annepidem.2012.07.010. Epub 2012 Sep 15.

15.

Physical activity, energy restriction, and the risk of pancreatic cancer: a prospective study in the Netherlands.

Heinen MM, Verhage BA, Goldbohm RA, Lumey LH, van den Brandt PA.

Am J Clin Nutr. 2011 Nov;94(5):1314-23. doi: 10.3945/ajcn.110.007542. Epub 2011 Sep 28.

PMID:
21955648
16.

Intake of vegetables, fruits, carotenoids and vitamins C and E and pancreatic cancer risk in The Netherlands Cohort Study.

Heinen MM, Verhage BA, Goldbohm RA, van den Brandt PA.

Int J Cancer. 2012 Jan 1;130(1):147-58. doi: 10.1002/ijc.25989. Epub 2011 Apr 27.

17.

NOS3 variants, physical activity, and blood pressure in the European Youth Heart Study.

Grøntved A, Andersen LB, Franks PW, Verhage B, Wareham NJ, Ekelund U, Loos RJ, Brage S.

Am J Hypertens. 2011 Apr;24(4):444-50. doi: 10.1038/ajh.2010.265. Epub 2011 Jan 20.

PMID:
21252862
18.

A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk.

Genkinger JM, Spiegelman D, Anderson KE, Bernstein L, van den Brandt PA, Calle EE, English DR, Folsom AR, Freudenheim JL, Fuchs CS, Giles GG, Giovannucci E, Horn-Ross PL, Larsson SC, Leitzmann M, Männistö S, Marshall JR, Miller AB, Patel AV, Rohan TE, Stolzenberg-Solomon RZ, Verhage BA, Virtamo J, Willcox BJ, Wolk A, Ziegler RG, Smith-Warner SA.

Int J Cancer. 2011 Oct 1;129(7):1708-17. doi: 10.1002/ijc.25794. Epub 2011 Mar 4.

19.

Active and passive smoking and the risk of pancreatic cancer in the Netherlands Cohort Study.

Heinen MM, Verhage BA, Goldbohm RA, van den Brandt PA.

Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1612-22. doi: 10.1158/1055-9965.EPI-10-0121. Epub 2010 May 25.

20.

Body mass index and von Hippel-Lindau gene mutations in clear-cell renal cancer: Results of the Netherlands Cohort Study on diet and cancer.

Smits KM, Schouten LJ, Hudak E, Verhage B, van Dijk BA, Hulsbergen-van de Kaa CA, Goldbohm RA, Oosterwijk E, van den Brandt PA.

Ann Epidemiol. 2010 May;20(5):401-4. doi: 10.1016/j.annepidem.2010.01.010.

PMID:
20382342
21.

Dietary folate and folate vitamers and the risk of pancreatic cancer in the Netherlands cohort study.

Keszei AP, Verhage BA, Heinen MM, Goldbohm RA, van den Brandt PA.

Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1785-91. doi: 10.1158/1055-9965.EPI-08-1220.

22.

Meat and fat intake and pancreatic cancer risk in the Netherlands Cohort Study.

Heinen MM, Verhage BA, Goldbohm RA, van den Brandt PA.

Int J Cancer. 2009 Sep 1;125(5):1118-26. doi: 10.1002/ijc.24387.

23.

Alcohol consumption and risk of pancreatic cancer in the Netherlands cohort study.

Heinen MM, Verhage BA, Ambergen TA, Goldbohm RA, van den Brandt PA.

Am J Epidemiol. 2009 May 15;169(10):1233-42. doi: 10.1093/aje/kwp028. Epub 2009 Mar 24.

PMID:
19318612
24.

Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies.

Genkinger JM, Spiegelman D, Anderson KE, Bergkvist L, Bernstein L, van den Brandt PA, English DR, Freudenheim JL, Fuchs CS, Giles GG, Giovannucci E, Hankinson SE, Horn-Ross PL, Leitzmann M, Männistö S, Marshall JR, McCullough ML, Miller AB, Reding DJ, Robien K, Rohan TE, Schatzkin A, Stevens VL, Stolzenberg-Solomon RZ, Verhage BA, Wolk A, Ziegler RG, Smith-Warner SA.

Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):765-76. doi: 10.1158/1055-9965.EPI-08-0880. Epub 2009 Mar 3.

25.

Fruit and vegetable consumption and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition.

Vrieling A, Verhage BA, van Duijnhoven FJ, Jenab M, Overvad K, Tjønneland A, Olsen A, Clavel-Chapelon F, Boutron-Ruault MC, Kaaks R, Rohrmann S, Boeing H, Nöthlings U, Trichopoulou A, John T, Dimosthenes Z, Palli D, Sieri S, Mattiello A, Tumino R, Vineis P, van Gils CH, Peeters PH, Engeset D, Lund E, Rodríguez Suárez L, Jakszyn P, Larrañaga N, Sánchez MJ, Chirlaque MD, Ardanaz E, Manjer J, Lindkvist B, Hallmans G, Ye W, Bingham S, Khaw KT, Roddam A, Key T, Boffetta P, Duell EJ, Michaud DS, Riboli E, Bueno-de-Mesquita HB.

Int J Cancer. 2009 Apr 15;124(8):1926-34. doi: 10.1002/ijc.24134.

26.

Glycemic load, glycemic index, and pancreatic cancer risk in the Netherlands Cohort Study.

Heinen MM, Verhage BA, Lumey L, Brants HA, Goldbohm RA, van den Brandt PA.

Am J Clin Nutr. 2008 Apr;87(4):970-7.

PMID:
18400721
27.

Tea and coffee drinking and ovarian cancer risk: results from the Netherlands Cohort Study and a meta-analysis.

Steevens J, Schouten LJ, Verhage BA, Goldbohm RA, van den Brandt PA.

Br J Cancer. 2007 Nov 5;97(9):1291-4. Epub 2007 Oct 9.

28.

Anthropometry and pancreatic cancer risk: an illustration of the importance of microscopic verification.

Verhage BA, Schouten LJ, Goldbohm RA, van den Brandt PA.

Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1449-54. Epub 2007 Jun 21.

29.

Site-specific familial aggregation of prostate cancer.

Verhage BA, Aben KK, Witjes JA, Straatman H, Schalken JA, Kiemeney LA.

Int J Cancer. 2004 Apr 20;109(4):611-7. Review.

30.

Inherited predisposition to prostate cancer.

Verhage BA, Kiemeney LA.

Eur J Epidemiol. 2003;18(11):1027-36. Review.

PMID:
14620936
31.

Genetic susceptibility to prostate cancer: a review.

Verhage BA, Kiemeney LA.

Fam Cancer. 2003;2(1):57-67. Review.

PMID:
14574167
32.

Spouse controls in family case-control studies: a methodological consideration.

Verhage BA, Aben KK, Straatman H, Verbeek AL, Beaty TH, Kiemeney LA.

Fam Cancer. 2003;2(2):101-8.

PMID:
14574159
33.

Allelic imbalance in hereditary and sporadic prostate cancer.

Verhage BA, van Houwelingen K, Ruijter TE, Kiemeney LA, Schalken JA.

Prostate. 2003 Jan 1;54(1):50-7.

PMID:
12481255
34.

[Characterisation of families with hereditary prostate cancer in the Netherlands].

Meulenbeld HJ, Verhage BA, Kil PJ, Kiemeney LA, Vasen HF.

Ned Tijdschr Geneeskd. 2002 Oct 12;146(41):1938-42. Dutch.

PMID:
12404910
35.

Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer.

Verhage BA, van Houwelingen K, Ruijter TE, Kiemeney LA, Schalken JA.

Int J Cancer. 2002 Aug 20;100(6):683-5. Erratum in: Int J Cancer 2002 Oct 20;101(6):600.

36.

Autosomal dominant inheritance of prostate cancer: a confirmatory study.

Verhage BA, Baffoe-Bonnie AB, Baglietto L, Smith DS, Bailey-Wilson JE, Beaty TH, Catalona WJ, Kiemeney LA.

Urology. 2001 Jan;57(1):97-101.

PMID:
11164151
37.

Genetic susceptibility to prostate cancer

Verhage BA, Kiemeney LA.

Eur Urol. 2000 Jul;38(1):121-30. No abstract available.

PMID:
10859454
38.

Prevalence of "syndrome X" features in parents of type 1 diabetic patients with or without nephropathy.

Verhage B, Vervoort G, Wolkotte C, Elving LD, Wetzels JF, Willems H, Smits P, Verbeek AL, Berden JH.

Diabetes Care. 1999 Jul;22(7):1048-52.

Supplemental Content

Loading ...
Support Center